Holders — by stockHoldings — by fund
Virtus Family Office LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001913482
$126.5M
disclosed book value
62
positions
6.2%
largest position share
Positions, as of 2026-06-30
top 62 of 62 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PXHINVESCO EXCH TRADED FD TR II | 279,203 | $7.8M | 6.2% |
| 2 | COPA HOLDINGS SA | 46,286 | $7.2M | 5.7% |
| 3 | TSMTAIWAN SEMICONDUCTOR MFG LTD | 14,988 | $7.2M | 5.7% |
| 4 | VCSHVANGUARD SCOTTSDALE FDS | 83,128 | $6.6M | 5.2% |
| 5 | SHGSHINHAN FINANCIAL GROUP CO L | 87,921 | $5.6M | 4.4% |
| 6 | ZTOZTO EXPRESS CAYMAN INC | 226,163 | $5.1M | 4% |
| 7 | SDVYFIRST TR EXCHANGE-TRADED FD | 108,889 | $4.7M | 3.7% |
| 8 | FLOTISHARES TR | 87,391 | $4.5M | 3.5% |
| 9 | PDDPDD HOLDINGS INC | 56,747 | $4.3M | 3.4% |
| 10 | VWOBVANGUARD WHITEHALL FDS | 63,166 | $4.2M | 3.4% |
| 11 | INMODE LTD | 259,325 | $3.8M | 3% |
| 12 | CROXCROCS INC | 22,588 | $2.7M | 2.2% |
| 13 | QCOMQUALCOMM INC | 13,357 | $2.5M | 2% |
| 14 | USRTISHARES TR | 36,059 | $2.4M | 1.9% |
| 15 | CMICUMMINS INC | 3,263 | $2.3M | 1.8% |
| 16 | QFINQFIN HOLDINGS INC | 144,382 | $2.3M | 1.8% |
| 17 | EFVISHARES TR | 28,029 | $2.1M | 1.7% |
| 18 | ADPAUTOMATIC DATA PROCESSING IN | 9,305 | $2.1M | 1.7% |
| 19 | DFEWISDOMTREE TR | 28,641 | $2.1M | 1.6% |
| 20 | SYFSYNCHRONY FINANCIAL | 26,935 | $2.0M | 1.6% |
| 21 | ABEVAMBEV SA | 619,337 | $2.0M | 1.6% |
| 22 | IAUISHARES GOLD TR | 25,970 | $2.0M | 1.6% |
| 23 | KFYKORN FERRY | 29,350 | $2.0M | 1.5% |
| 24 | VEEVVEEVA SYS INC | 10,965 | $1.9M | 1.5% |
| 25 | DHSWISDOMTREE TR | 16,296 | $1.9M | 1.5% |
| 26 | STIPISHARES TR | 17,903 | $1.8M | 1.4% |
| 27 | UTHRUNITED THERAPEUTICS CORP DEL | 3,366 | $1.8M | 1.4% |
| 28 | PYPLPAYPAL HLDGS INC | 42,080 | $1.8M | 1.4% |
| 29 | PAYCPAYCOM SOFTWARE INC | 14,285 | $1.8M | 1.4% |
| 30 | CMCSACOMCAST CORP NEW | 69,509 | $1.7M | 1.3% |
| 31 | PFEPFIZER INC | 70,574 | $1.7M | 1.3% |
| 32 | RMDRESMED INC | 8,634 | $1.7M | 1.3% |
| 33 | UHSUNIVERSAL HLTH SVCS INC | 11,082 | $1.6M | 1.3% |
| 34 | EWJVISHARES TR | 37,323 | $1.6M | 1.3% |
| 35 | CTSHCOGNIZANT TECHNOLOGY SOLUTIO | 37,180 | $1.4M | 1.1% |
| 36 | PDNINVESCO EXCH TRADED FD TR II | 30,937 | $1.4M | 1.1% |
| 37 | PRFINVESCO EXCHANGE TRADED FD T | 23,807 | $1.3M | 1% |
| 38 | NTAPNETAPP INC | 7,926 | $1.2M | 1% |
| 39 | MRKMERCK & CO INC | 7,473 | $966,633 | 0.8% |
| 40 | CNICANADIAN NATL RY CO | 7,984 | $952,012 | 0.8% |
| 41 | MEDMEDIFAST INC | 79,060 | $838,827 | 0.7% |
| 42 | FNFFIDELITY NATL FINL INC | 17,640 | $831,902 | 0.7% |
| 43 | SHLDGLOBAL X FDS | 13,877 | $828,596 | 0.7% |
| 44 | MTUMISHARES TR | 2,389 | $819,021 | 0.6% |
| 45 | GILDGILEAD SCIENCES INC | 6,114 | $772,443 | 0.6% |
| 46 | CLXCLOROX CO DEL | 8,073 | $770,487 | 0.6% |
| 47 | VFMOVANGUARD WELLINGTON FD | 3,032 | $756,514 | 0.6% |
| 48 | GPZVANECK ETF TRUST | 34,289 | $735,156 | 0.6% |
| 49 | PRFZINVESCO EXCHANGE TRADED FD T | 12,740 | $710,510 | 0.6% |
| 50 | INGRINGREDION INC | 7,430 | $703,695 | 0.6% |
| 51 | IMTMISHARES TR | 12,982 | $692,330 | 0.5% |
| 52 | XOVRENTREPRENEURSHARES SERIES TR | 31,746 | $668,253 | 0.5% |
| 53 | RYAAYRYANAIR HOLDINGS PLC | 8,971 | $581,005 | 0.5% |
| 54 | ROKTSPDR SERIES TRUST | 3,802 | $454,263 | 0.4% |
| 55 | EWNISHARES INC | 5,731 | $403,119 | 0.3% |
| 56 | EWYISHARES INC | 1,920 | $387,648 | 0.3% |
| 57 | GOOGLALPHABET INC | 1,032 | $368,806 | 0.3% |
| 58 | NVDANVIDIA CORPORATION | 1,799 | $359,962 | 0.3% |
| 59 | ROBTFIRST TR EXCHANGE TRADED FD | 5,449 | $306,561 | 0.2% |
| 60 | ICON PLC | 1,340 | $232,771 | 0.2% |
| 61 | CRMSALESFORCE INC | 1,287 | $201,907 | 0.2% |
| 62 | PROKPROKIDNEY CORP | 27,500 | $56,100 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.